Silberstein was part of the research group that reexamined 228 people who suffered from severe migraines. About half of the patients received a series of 10 to 25 Botox injections in their head, neck or shoulders every three months. The other half received saline injections.
After six months, Botox failed to show a reduction in migraine headaches compared to a placebo. But looking at patients who suffered more frequent attacks, Botox was linked to a 20 percent greater reduction in migraines, according to results presented at the headache meeting by David Dodick, MD, of the Mayo Clinic in Arizona.
The Botox group suffered an average of 14 migraines a month before the study. After receiving treatment, headaches dropped to six a month. In the saline group, patients went from nearly 13 migraines a month to about eight.
Another analysis, led by Frederick Freitag, DO, of the Diamond Headache Clinic in Chicago, found that Botox could reduce the need for pain medication. Patients who took Botox reduced their use of ibuprofen and other pain relievers by 60 percent compared to 35 percent with saline injections.
Botox in Practice
Freitag, who has treated his migraine patients with Botox for more than a decade, said that people who have four to eight headaches a month generally don't respond to this therapy, but those with more challenging headaches might. There are several treatments that are used to prevent migraines, including anticonvulsants, blood pressure medications and anti-depressants.
The newest treatment is Topamax, which was specifically approved by the FDA for migraine prevention. Freitag said that Botox seems to have the same effect as antidepressants in relieving headache frequency. "About one third of patients will show some benefit," he said.
Botox, however, can also make your face feel frozen, and those who hope to have fewer age lines in addition to fewer headaches may come away disappointed. The areas of the body that doctors need to inject Botox is often different for migraines than for cosmetic reasons. "They rarely overlap," Freitag said. "Patients will look the same."